Soc Telemed, Inc. TLMD
We take great care to ensure that the data presented and summarized in this overview for SOC Telemed, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TLMD
Top Purchases
Top Sells
About TLMD
Insider Transactions at TLMD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 06
2022
|
Barbara Peterson Byrne |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
Thomas J. Carella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,591
-100.0%
|
$271,773
$3.0 P/Share
|
|
Apr 06
2022
|
Gyasi C. Chisley |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,150
-100.0%
|
$132,450
$3.0 P/Share
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
401,243
-100.0%
|
-
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
3,316,679
-100.0%
|
-
|
|
Apr 06
2022
|
Joseph P Greskoviak |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,185
-100.0%
|
$237,555
$3.0 P/Share
|
|
Apr 06
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,677
-100.0%
|
$47,031
$3.0 P/Share
|
|
Apr 06
2022
|
Eunice Kim General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,168
-100.0%
|
$66,504
$3.0 P/Share
|
|
Apr 06
2022
|
Amr Kronfol |
SELL
Sale (or disposition) back to the issuer
|
Direct |
101,325
-100.0%
|
$303,975
$3.0 P/Share
|
|
Apr 06
2022
|
Anne Mc George |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
David Mikula Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
496,576
-100.0%
|
$1,489,728
$3.0 P/Share
|
|
Apr 06
2022
|
Steven J Shulman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,112,291
-100.0%
|
$3,336,873
$3.0 P/Share
|
|
Apr 06
2022
|
Warburg Pincus & Co. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
67,749,930
-100.0%
|
$203,249,790
$3.0 P/Share
|
|
Apr 01
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,491
-7.32%
|
$12,982
$2.98 P/Share
|
|
Dec 20
2021
|
David Mikula Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+32.22%
|
-
|
|
Dec 20
2021
|
Christopher M. Gallagher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,080,000
+19.72%
|
-
|
|
Jun 03
2021
|
Barbara Peterson Byrne |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+26.51%
|
-
|
|
Jun 03
2021
|
Thomas J. Carella |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+18.87%
|
-
|
|
Jun 03
2021
|
Joseph P Greskoviak |
BUY
Grant, award, or other acquisition
|
Direct |
25,982
+13.97%
|
-
|
|
Jun 03
2021
|
Amr Kronfol |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+17.21%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders